Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand?

Ocular blood flow as a clinical observation: Value, limitations and data analysis

(2020) Alon Harris et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Current management of glaucoma

(2019) Jed Lusthaus et al.   MEDICAL JOURNAL OF AUSTRALIA

Glaucoma: Current treatment and impact of advanced drug delivery systems

(2019) Khushwant S. Yadav et al.   LIFE SCIENCES

Rho-Associated Kinase Inhibitors: Evolving Strategies in Glaucoma Treatment

(2019) Emily M. Schehlein et al.   DRUGS

Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension

(2019) Fotis Topouzis et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

Implication of sulfonylurea derivatives as prospective inhibitors of human carbonic anhydrase II

(2018) Danish Idrees et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study

(2018) Sang Wook Jin et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

A Worldwide Price Comparison of Glaucoma Medications, Laser Trabeculoplasty, and Trabeculectomy Surgery

(2018) Peter Y. Zhao et al.   JAMA Ophthalmology

Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation

(2017) Jed Asher Lusthaus et al.   Expert Opinion On Drug Safety

The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure

(2017) Leonard K. Seibold et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial

(2016) R D Fechtner et al.   EYE

Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma

(2016) Tianjing Li et al.   OPHTHALMOLOGY

Primary Open-Angle Glaucoma Preferred Practice Pattern® Guidelines

(2016) Bruce E. Prum et al.   OPHTHALMOLOGY

Controversies in the pathophysiology and management of hyphema

(2016) Svati Bansal et al.   SURVEY OF OPHTHALMOLOGY

Brinzolamide/Brimonidine: A Review of Its Use in Patients with Open-Angle Glaucoma or Ocular Hypertension

(2015) Sarah L. Greig et al.   DRUGS & AGING

Design, Synthesis, and Evaluation of NO-Donor Containing Carbonic Anhydrase Inhibitors To Lower Intraocular Pressure

(2015) Qinhua Huang et al.   JOURNAL OF MEDICINAL CHEMISTRY

Efficacy and Safety of Glaucoma Patients' Switch from a 2% Dorzolamide/0.5% Timolol Fixed-Combination Brand-Name Drug to Its Generic Counterpart

(2015) Yong Il Kim et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Nitric Oxide Donors and Selective Carbonic Anhydrase Inhibitors: A Dual Pharmacological Approach for the Treatment of Glaucoma, Cancer and Osteoporosis

(2015) Simone Carradori et al.   MOLECULES

Long-Term Effects of Multiple Intravitreal Antivascular Endothelial Growth Factor Injections on Intraocular Pressure

(2014) Yoon Jeon Kim et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Brinzolamide plus brimonidine for the treatment of glaucoma: an update

(2014) Sky K Chew et al.   EXPERT OPINION ON PHARMACOTHERAPY

Glaucoma prescribing trends in England 2000 to 2012

(2014) A J Connor et al.   EYE

Twice-Daily Brinzolamide/Brimonidine Fixed Combination versus Brinzolamide or Brimonidine in Open-Angle Glaucoma or Ocular Hypertension

(2014) Tin Aung et al.   OPHTHALMOLOGY

Comparative Effectiveness of Treatments for Open-Angle Glaucoma: A Systematic Review for the U.S. Preventive Services Task Force

(2013) Michael V. Boland et al.   ANNALS OF INTERNAL MEDICINE

Effects of antiglaucoma drugs on blood flow of optic nerve heads and related structures

(2013) Chihiro Mayama et al.   JAPANESE JOURNAL OF OPHTHALMOLOGY

A multivalent approach towards linked dual-pharmacology prostaglandin F receptor agonist/carbonic anhydrase-II inhibitors for the treatment of glaucoma

(2012) Daniel D. Long et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Retrobulbar Hemodynamics Before and After Oculopression With and Without Dorzolamide

(2012) Klaudia Karola Huber-van der Velden et al.   CURRENT EYE RESEARCH

Intraocular pressure and ocular hemodynamics in patients with primary open-angle glaucoma treated with the combination of morning dosing of bimatoprost and dorzolamide hydrochloride

(2011) Andrzej Stankiewicz et al.   ACTA OPHTHALMOLOGICA

A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology

(2011) Francesca Fabrizi et al.   JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension

(2010) Konstantin Gugleta   CURRENT MEDICAL RESEARCH AND OPINION

Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma

(2009) Antonio Martínez et al.   ACTA OPHTHALMOLOGICA

Ocular blood flow and oxygen delivery to the retina in primary open-angle glaucoma patients: the addition of dorzolamide to timolol monotherapy

(2009) Brent Siesky et al.   ACTA OPHTHALMOLOGICA

Dorzolamide-timolol combination and retinal vessel oxygen saturation in patients with glaucoma or ocular hypertension

(2009) S Traustason et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

A Comparison of the Long-Term Effects of Dorzolamide 2% and Brinzolamide 1%, Each Added to Timolol 0.5%, on Retrobulbar Hemodynamics and Intraocular Pressure in Open-Angle Glaucoma Patients

(2009) Antonio Martínez et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Literature Review and Meta-Analysis of Topical Carbonic Anhydrase Inhibitors and Ocular Blood Flow

(2009) Brent Siesky et al.   SURVEY OF OPHTHALMOLOGY